As Global Head of Novartis Technical Operations (NTO), Steffen Lang leads the company’s manufacturing and supply organization. He is responsible for around 25,000 associates and a worldwide network of more than 50 production facilities that supplied 72 billion treatments to patients in 2020.
Under Steffen’s leadership, NTO is reimagining manufacturing and supply to better serve the needs of patients and the business while improving environmental performance. His mission is to transform the way NTO works, matching its manufacturing capacity and capabilities to the changing demands of the Novartis strategy and product portfolio. This involves constant technological innovation to enable the production of advanced therapeutic platforms such as cell and gene therapies.
In NTO, we are inspired by our patients, steered by our people, and powered by data science and process technology. I am proud that through the diversity and unique expertise of our network, our collaborative approach, and our strong focus on operational excellence, NTO is enabling Novartis to deliver transformational solutions that are helping us to reimagine medicine.
NTO is also on track to achieve ambitious sustainability goals, which include eliminating PVC in packaging and becoming carbon neutral by 2030.
Steffen draws on a wealth of experience in the pharmaceutical industry, with a career that ranges from research through development to manufacturing and supply. He joined Novartis in 1994 as Head of Laboratory in Research, and held positions of increasing responsibility before taking on his present role in 2017.
In his spare time, Steffen enjoys indoor and outdoor sports, and spending time with his family and friends.